ATC code V10
ATC code V10 Therapeutic radiopharmaceuticals is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup V10 is part of the anatomical group V Various.[4]
| ATC codes |
|---|
| V Various |
| V01 Allergens |
| V03 All other therapeutic products |
| V04 Diagnostic agents |
| V06 General nutrients |
| V07 All other non-therapeutic products |
| V08 Contrast media |
| V09 Diagnostic radiopharmaceuticals |
| V10 Therapeutic radiopharmaceuticals |
| V20 Surgical dressings |
|
|
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QV10.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
V10A Anti-inflammatory agents
V10AA Yttrium (90Y) compounds
- V10AA01 Yttrium (90Y) citrate colloid
- V10AA02 Yttrium (90Y) ferrihydroxide colloid
- V10AA03 Yttrium (90Y) silicate colloid
V10AX Other anti-inflammatory therapeutic radiopharmaceuticals
- V10AX01 Phosphorus (32P) chromicphosphate colloid
- V10AX02 Samarium (153Sm) hydroxyapatite colloid
- V10AX03 Dysprosium (165Dy) colloid
- V10AX04 Erbium (169Er) citrate colloid
- V10AX05 Rhenium (186Re) sulfide colloid
- V10AX06 Gold (198Au) colloidal
V10B Pain palliation (bone seeking agents)
V10BX Various pain palliation radiopharmaceuticals
- V10BX01 Strontium (89Sr) chloride
- V10BX02 Samarium (153Sm) lexidronam
- V10BX03 Rhenium (186Re) etidronic acid
V10X Other therapeutic radiopharmaceuticals
V10XA Iodine (131I) compounds
- V10XA01 Sodium iodide (131I)
- V10XA02 Iobenguane (131I)
- V10XA03 Iodine (131I) omburtamab
- V10XA53 Tositumomab/iodine (131I) tositumomab
V10XX Various therapeutic radiopharmaceuticals
- V10XX01 Sodium phosphate (32P)
- V10XX02 Ibritumomab tiuxetan (90Y)
- V10XX03 Radium (223Ra) dichloride
- V10XX04 Lutetium (177Lu) oxodotreotide
References
- "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- "ATC/DDD Index 2022: code V10". WHO Collaborating Centre for Drug Statistics Methodology.
- "ATCvet Index 2022: code QV10". WHO Collaborating Centre for Drug Statistics Methodology.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.